DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAU) Operating income
DRUGS MADE IN AMERICA ACQUISITION CORP. (DMAAU) annual operating income history from SEC filings — each fiscal year as reported.
-$2.8MFY2025
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$2.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More DMAAU financial trends
DMAAU RevenueDMAAU Net incomeDMAAU Net marginDMAAU Gross profitDMAAU Gross marginDMAAU Operating marginDMAAU Operating cash flowDMAAU Free cash flowDMAAU Capital expendituresDMAAU Return on equityDMAAU Stock buybacksDMAAU Dividends paidDMAAU Total assetsDMAAU Total liabilitiesDMAAU Shareholders’ equityDMAAU overview →